Blog
[printfriendly]
-
Feb 11, 2019What is metabolic syndrome, what does it have to do with neuropathy, and what can we do about it?
by Shanna Patterson, MD Around the New Year many people think about resolutions. For those of us contemplating how we can be our healthiest selves, this often includes recommitting to… -
Feb 6, 2019Key Data from FPN Patient Registry Highlighted in Top Medical Journal
In January 2019, a study was published by the Journal of the Peripheral Nervous System on the design and characteristics of patient data collected from the Peripheral Neuropathy Research Registry… -
Jan 24, 2019Mike’s Story: How I Keep My Exercise Goals
Mike Foxworth, a FPN member and member of the Metro DC Area Support Group, shares how exercising with a group helps him keep his fitness goals. Research suggests that exercise… -
Jan 22, 2019Gene Therapy Blocks Peripheral Nerve Damage in Mice
In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various… -
Jan 15, 2019Phil’s Story: Hand-Controlled Driving Part 2
In Part 1 of his story, Phil, a Charlotte area member and a member of our only Virtual Support Group, shared his experiences with learning to drive in a hands… -
Jan 10, 2019FPN Welcomes Newest Research Partner in Washington University School of Medicine in St. Louis
The Foundation for Peripheral Neuropathy (FPN) continues to build a network of leading neurological consortium partner clinics. Starting in January 2019, FPN is pleased to announce the newest research partner… -
Dec 20, 2018
Stem Cell Treatments: A real hope or false promise?
The Foundation for Peripheral Neuropathy receives many inquiries from patients about stem cell treatments for peripheral neuropathy. An article, ‘Snake Oil’ Stem Cell Clinics Peddle False Hope for High Prices… -
Dec 20, 2018IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S.
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study,…